The key signaling pathways through which compound P3 functions in the treatment of T2DM include neuroactive ligand–receptor interaction, calcium signaling pathway, PI3K-Akt signaling pathway, and pathways in cancer. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.